Rapid developments in recent years in basic science and
pharmacology has greatly increased understanding of the causes of
anxiety disorders. This has led to a large number of new drug
treatments from the pharmaceutical industry. This book makes sense
of these advances and presents a coherent account of diagnosis and
management from the clinical point of view.
Chapters are in the form of surveys and digests of the recent
literature and are interspersed with clinical guidelines,
diagnostic and therapeutic points and are well illustrated.
Innehållsförteckning
Part 1: Introduction.
1 Conceptual Antecedents of the Anxiety Disorders.
Part 2: Symptoms and Syndromes.
2 Relationships Among Anxiety Disorders: Patterns and
Implications.
3 Panic Disorder: Symptoms and Syndromes.
4 Genralized Anxiety Disorder.
5 Post-traumatic Stress Disorder.
6 Obsessive-compulsive Disorder.
7 Social Anxiety Disorder.
8 Sleep Aspects in Anxiety Disorder.
9 Childhood Antecedents of Adult Anxiety Disorders.
10 Anxiety and Schizophrenia.
Part 3: Mechanisms.
11 Neurochemical Aspects of Anxiety.
12 Brain Imaging and Anxiety Disorders.
13 Genetics Dissection of Anxiety and Related Disorders.
14 Respiration and Anxiety.
15 Pharmacological Challenge Agents in Anxiety.
16 Panic Disorders and Medical Illness.
Part 4: Treatments.
17 Benzodiazepines.
18 Selective Serotonin Reuptake Inhibitors innthe Treatment of
the Anxiety Disorders.
19 Treatment of the Anxiety Disorders with Tricyclic
Antidepressants.
20 Buspirone in the Treatment of Anxiety Disorders.
21 Antihistamines in the Treatment of Psychic and Somatic
Anxiety States.
22 Anxiety Disorders: New Antidepressants.
23 Cognitive Behavioral Treatment of Anxiety Disorders.
24 Exposure Therapy and Treatment of Anxiety Disorders.
25 Anxiety Disorders: Alternative Drug Treatments.
26 Physical Treatments.
27 Herbal Therapy and Anxiety.
Part 5: Conclusion.
28 Anxiety Disorders: Current Needs and Future Prospects.
Index
Om författaren
David John Nutt is a British neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He was until 2009 a professor at the University of Bristol heading their Psychopharmacology Unit.
James C. Ballenger is the editor of Anxiety Disorders, published by Wiley.
Fler e-böcker från samma författare (r) / Redaktör
143 600 E-böcker i denna kategori
